Coverage with evidence development: what to consider

Affiliations

¹ Center for Alzheimer's Care, Imaging, and Research, Department of Neurology, University of Utah, Salt Lake City.
² Clinical Research Compliance and Education, University of Utah, Salt Lake City.
³ Department of Neurology, University of Utah, Salt Lake City4Department of Radiology, University of Utah, Salt Lake City5Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, Salt Lake City, Utah.

Review

Norman L Foster et al. JAMA Neurol. 2014 Apr.

. 2014 Apr;71(4):399-400.

doi: 10.1001/jamaneurol.2013.5812.

¹ Center for Alzheimer's Care, Imaging, and Research, Department of Neurology, University of Utah, Salt Lake City.
² Clinical Research Compliance and Education, University of Utah, Salt Lake City.
³ Department of Neurology, University of Utah, Salt Lake City4Department of Radiology, University of Utah, Salt Lake City5Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, Salt Lake City, Utah.

No abstract available

Cited by

Clinical and Scientific Challenges to Effectiveness Studies Under Coverage with Evidence Development in Alzheimer's Disease.
Morin PJ, Zhang Q, Xia W, Miller D, Querfurth H, Tahami Monfared AA. Morin PJ, et al. Neurol Ther. 2023 Jun;12(3):721-726. doi: 10.1007/s40120-023-00462-z. Epub 2023 Mar 18. Neurol Ther. 2023. PMID: 36933140 Free PMC article.
Living laboratory: whole-genome sequencing as a learning healthcare enterprise.
Angrist M, Jamal L. Angrist M, et al. Clin Genet. 2015 Apr;87(4):311-8. doi: 10.1111/cge.12461. Epub 2014 Sep 6. Clin Genet. 2015. PMID: 25045831 Free PMC article. Review.